Emerging Concepts and Approaches in the Treatment of Food Allergy: What Managed Care Professionals Need to Know

This activity was originally broadcast in conjunction with AMCP 2024.

Program Description

In the US, food allergies can affect both adults and children, with about one-third of children retaining their allergies into adulthood. Current approaches for the management of severe food-related reactions have their limitations. Newer research and guidelines to improve patients’ desensitization and tolerance to food allergens includes a mix of dietary interventions, biological therapies, and allergen immunotherapy. Managed care professionals must be aware of the growing body of clinical evidence supporting the role of biologics and immunomodulators targeting immunoglobulin E (IgE)-mediated food allergies. This program will focus on clinical data for immunomodulators and emerging biologics that target IgE-mediated inflammatory pathways for the treatment of food allergies. It will also explore how emerging therapeutic approaches can be integrated into treatment protocols for food allergies by filling the existing gaps in patient management.

Target audience: Managed care pharmacists

Type of activity: Application
Release date: May 3, 2024
Expiration date: May 3, 2025

Time to complete activity: 1.5 hours

Learner level: Foundational, Intermediate
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Analyze the treatment and socioeconomic burden associated with the contemporary approach in managing food allergies.
• Show the trends in immunoglobulin E (IgE)-mediated food allergies through clinical trial data for immunomodulators and emerging biologics that target inflammatory pathways in food allergies.
• Investigate strategies for the integration of treatment protocols aimed at alleviating the burden of IgE-mediated food allergies and filling the existing gaps in patient management, with a focus on exploring innovative therapeutic approaches.